Effect of three different regimens of repeated methamphetamine on rats’ cognitive performance
- 176 Downloads
Neurocognitive impairment in response to methamphetamine (MA) has been proven in a variety of experimental and clinical studies. Elucidation of the underlying mechanisms of MA-induced cognitive deficits and finding preventive/therapeutic approaches need best-suited animal models. In modeling repeated MA exposure, while some believes that escalating doses simulate drug abuse conditions, others believe this regimen confers a preconditioning protection. The present study aimed to compare the effects of three different regimens of repeated MA administration on memory and cognitive function of adult rats. Rats in two different experimental groups were treated with escalating paradigms consisted of twice-daily i.p. injections; 1–4 mg/kg over 7 days or 1–10 mg/kg over 10 days. The third group received twice-daily doses of 15 mg/kg every other day over 14 days. Spatial working memory, novel object recognition task and anxiety-like behavior were measured sequentially in all MA-treated rats and vehicle-treated controls started from day 8 after last injection. All MA regimens decreased rates of spontaneous alternation in Y-maze and increased anxiety-like response. Short-term recognition memory was unchanged across all MA-treated animals, while long-term memory was impaired in the second and third MA regimen. Though MA deleterious effect especially in recognition memory is somehow dose dependent, preconditioning effect of increasing doses may be ruled out at least in the case of parameters measured here.
KeywordsMethamphetamine Repeated doses Neurocognitive impairment
The authors are thankful to the Neuroscience Research Center of Shahid Beheshti University of Medical Sciences for funding this research.
Compliance with ethical standards
Conflict of interest
The authors declare no conflict of interest.
- Braren SH, Drapala D, Tulloch IK, Serrano PA (2014) Methamphetamine-induced short-term increase and long-term decrease in spatial working memory affects protein Kinase M zeta (PKMζ), dopamine, and glutamate receptors. Front Behav Neurosci 8:438. doi: 10.3389/fnbeh.2014.00438 CrossRefPubMedPubMedCentralGoogle Scholar
- Cadet JL, Brannock C, Ladenheim B, McCoy MT, Beauvais G, Hodges AB, Lehrmann E, Wood WH 3rd, Becker KG, Krasnova IN (2011) Methamphetamine preconditioning causes differential changes in striatal transcriptional responses to large doses of the drug. Dose Response 9(2):165–181CrossRefPubMedGoogle Scholar
- Ghazvini H, Khaksari M, Esmaeilpour K, Shabani M, Asadi-Shekaari M, Khodamoradi M, Sheibani V (2016) Effects of treatment with estrogen and progesterone on the methamphetamine-induced cognitive impairment in ovariectomized rats. Neurosci Lett 619:60–67. doi: 10.1016/j.neulet.2016.02.057 CrossRefPubMedGoogle Scholar
- Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R, Methamphetamine Treatment Project Corporate Authors (2010) Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning. Am J Addict 19(5):385–390. doi: 10.1111/j.1521-0391.2010.00061.x CrossRefPubMedPubMedCentralGoogle Scholar
- Grace CE, Schaefer TL, Herring NR, Graham DL, Skelton MR, Gudelsky GA, Williams MT, Vorhees CV (2010) Effect of a neurotoxic dose regimen of (+)-methamphetamine on behavior, plasma corticosterone, and brain monoamines in adult C57BL/6 mice. Neurotoxicol Teratol 32(3):346–355CrossRefPubMedPubMedCentralGoogle Scholar
- Kamei H, Nagai T, Nakano H, Togan Y, Takayanagi M, Takahashi K, Kobayashi K, Yoshida S, Maeda K, Takuma K, Nabeshima T, Yamada K (2006) Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced ERK1/2 activation in the prefrontal cortex of mice. Biol Psychiatry 59(1):75–84CrossRefPubMedGoogle Scholar
- Kitanaka N, Kitanaka J, Tatsuta T, Tanaka K, Watabe K, Nishiyama N, Morita Y, Takemura M (2010) Withdrawal from fixed-dose injection of methamphetamine decreases cerebral levels of 3-methoxy-4-hydroxyphenylglycol and induces the expression of anxiety-related behavior in mice. Neurochem Res 35(5):749–760. doi: 10.1007/s11064-010-0132-4 CrossRefPubMedGoogle Scholar
- Lee KW, Kim HC, Lee SY, Jang CG (2011) Methamphetamine-sensitized mice are accompanied by memory impairment and reduction of N-methyl-d-aspartate receptor ligand binding in the prefrontal cortex and hippocampus. Neuroscience 178:101–107. doi: 10.1016/j.neuroscience.2011.01.025 (Epub 2011 Jan 19) CrossRefPubMedGoogle Scholar
- London ED, Berman SM, Voytek B, Simon SL, Mandelkern MA, Monterosso J, Thompson PM, Brody AL, Geaga JA, Hong MS, Hayashi KM, Rawson RA, Ling W (2005) Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers. Biol Psychiatry 58(10):770–778CrossRefPubMedGoogle Scholar
- Madden LJ, Flynn CT, Zandonatti MA, May M, Parsons LH, Katner SN, Henriksen SJ, Fox HS (2005) Modeling human methamphetamine exposure in nonhuman primates: chronic dosing in the rhesus macaque leads to behavioral and physiological abnormalities. Neuropsychopharmacology 30(2):350–359CrossRefPubMedGoogle Scholar
- Reichel CM, Schwendt M, McGinty JF, Olive MF, See RE (2011) Loss of object recognition memory produced by extended access to methamphetamine self-administration is reversed by positive allosteric modulation of metabotropic glutamate receptor 5. Neuropsychopharmacology 36(4):782–792. doi: 10.1038/npp.2010.212 CrossRefPubMedGoogle Scholar
- Woods SP, Rippeth JD, Conover E, Gongvatana A, Gonzalez R, Carey CL, Cherner M, Heaton RK, Grant I, HIV Neurobehavioral Research Center Group (2005) Deficient strategic control of verbal encoding and retrieval in individuals with methamphetamine dependence. Neuropsychology 19(1):35–43CrossRefPubMedGoogle Scholar
- Zhong N, Jiang H, Du J, Zhao Y, Sun H, Xu D, Li C, Zhuang W, Li X, Hashimoto K, Zhao M (2016) The cognitive impairments and psychological wellbeing of methamphetamine dependent patients compared with health controls. Prog Neuropsychopharmacol Biol Psychiatry 69:31–37. doi: 10.1016/j.pnpbp.2016.04.005 CrossRefPubMedGoogle Scholar